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Abstract 
PH monitoring is not capable of detecting all types of reflux, especially when the amount of acid is very low or not 
at all in the refluxate. Multichannel intraluminal impedance-pH monitoring (MII-pH) is used as a new method to 
assess bolus transport. The types of reflexes including acid, weak acid and weak alkaline MII-pH is capable of 
distinguishing more reflux episodes based upon use of physical and chemical parameters of the refluxate, leads 
to a diagnosis of normal acid reflux from abnormal nonacidic reflux. 24-h oesophagal pH monitoring can be 
effectively used to assess the potential relationship between symptoms and refluxes. MII-pH is capable of 
distinguishing more reflux episodes based upon use of physical and chemical parameters of the refluxate, leads 
to a diagnosis of normal acid reflux from abnormal nonacidic reflux. It can be used to confirm gastro-oesophagal 
reflux episodes, where has a sensitivity and specificity for diagnosing GERD in comparison with endoscopy or pH-
metry. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Introduction 
 
Gastro-oesophagal reflux disease (GERD) is 
a digestive disorder, which is associated with the 
flowing back of acid and gastric contents to the 
oesophagus. GERD occurs when gastroesophageal 
reflux causes symptoms and/or unpleasant 
complications, and it is described as the most 
common chronic upper gastrointestinal disease. 
A variety of GERD clinical symptoms are 
commonly seen in this condition include heartburn, 
regurgitation, nausea, vomiting, belching, heavy 
stomach feelings, and epigastric pain, while atypical 
symptoms are associated with hoarse voice, 
coughing, sore throat or ear pain [1]. It is noteworthy 
that typical GERD has been described to be 
troublesome heartburn with/without regurgitation [2] 
[3] 
Proton-pump inhibitors are commonly used as 
a treatment option for patients with typical symptoms 
of the disease, which is more than 80% effective in 
treating esophagitis and heartburn [2] [4]. Empirical 
treatment with PPIs is a method that initially leads to 
an assessment of more individuals with persistent 
symptoms despite the use of repressive therapies [5]. 
The most common cause of failure is the misdiagnosis 
of GERD with various functional disorders [6]. It has 
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been revealed that weakly acidic reflux episodes are 
other causative factors involved in the symptoms of 
heartburn and regurgitation [7] [8]. 
 Diagnostic evaluations of patients with PPI-
refractory heartburn and uninvestigated PPI-
responsive cases are required in the absence of alarm 
manifestation [2] [4]. Patients suffering from GERD 
are generally divided into two groups of non-erosive 
reflux disease and erosive esophagitis [9]. Methods 
such as diet and lifestyle changes and protein pump 
inhibitors (PPIs) are recommended for the treatment 
of NERD [1]. 
It has been reported that endoscopy revealed 
a small percentage of patients with erosive reflux 
disease, whereas most patients with endoscopy-
negative heartburn are considered as non-erosive 
reflux disease. The criteria for this attitude is 
described as abnormal results in pH or impedance-pH 
monitoring, while the normal results and unfavourable 
response to a PPI are categorised as functional 
heartburn [2] [10] [11]. 
Functional heartburn (FH) treatment is most 
commonly performed with an individual approach and 
is mostly an experimental therapy because the poor 
response to the treatment of acid suppression is 
abundant in which the psycho-pathological component 
is also present. Nevertheless, it can be said that 
monitoring heartburn in patients who are diagnosed 
with non-erosive reflux disease will be an important 
factor in distinguishing these individuals from those 
who have true FH [12] [13]. Other methods other than 
endoscopy should be used for monitoring of gastro-
oesophagal reflux. Gastro-oesophageal refluxate, 
independent of mucosal lesions, is initially performed 
using PH monitoring in the distal oesophagus. This 
method is routinely used as a gold standard for 
diagnosis and monitoring of treatment interventions 
[5]. PH monitoring is not capable of detecting all types 
of reflux, especially when the amount of acid is very 
low or not at all in the refluxate. Multichannel 
intraluminal impedance-pH monitoring (MII-pH) is 
used as a new method to assess bolus transport and 
types of reflexes including acid, weak acid and weak 
alkaline [14]. The current paper was aimed to discuss 
the technical aspects in implementing PH monitoring 
and impedance-pH monitoring techniques for the 
detection of reflux. 
 
 
Methods 
 
 We have collected all documents using a 
curated medical database such as PubMed, Scopus 
Embase, MEDLINE, Web of Science Core Collection, 
Google Scholar, etc. 
 
Results and Discussion 
 
A 24-h oesophagal pH Monitoring can be 
effectively used to assess the potential relationship 
between symptoms and refluxes. Oesophagal pH 
monitoring is routinely applied using catheter-based 
systems (Single sensor or Dual sensor) and recently 
without pH catheter (wireless Bravo pH capsule or 
OMOM PH capsule). 
This method is performed in cases which do 
not respond to medication, where there are common 
GERD symptoms, such as heartburn and 
regurgitation. In terms of atypical GERD symptoms 
such as chest pain, cough, hoarseness, wheezing, 
and a sore throat or ear pain, if symptoms are caused 
by gastro-oesophageal reflux, monitoring of PH can 
be occasionally applied for determining therapeutic 
drug effectiveness against GERD, where it is effective 
in determining the association of times of reflux with 
atypical symptoms. This test is usually performed as 
part of procedures before performing an antireflux 
operation [15] [16]. 
A cutoff pH 4.0 is usually accepted by the 
most specialist for diagnosis of acid reflux episodes in 
both catheter-based and catheter-free devices due to 
the decreased pepsin's proteolytic activity in solutions 
with a pH higher than 4.0 and the reporting of 
symptoms of common reflux in intraesophageal pH 
below 4.0 [5] [17]. However, a pH of fewer than 4.0 
units may be associated with the acid swallowing, and 
oesophagal exposure is likely to be overestimated. 
Furthermore, it has recognised that the proteolytic 
activity of pepsins is mainly needed for oesophagal 
mucosa damage [2] [18]. It should be into 
consideration that pepsin's proteolytic activity can be 
sustained up to pH 6.0 [19]. Moreover, healing of 
mucosal damage is achieved through reparative 
processes, whereas stopped at pH 6.5 [2] [20]. 
DeMeester score has been previously 
provided to quantify the exposure of the distal 
oesophagus to the acid based upon the use of six 
parameters where a DeMeester score > 14.72 shows 
reflux [5] [21], (Figure 1). 
 
Figure 1: DeMeester Score of 24 h Esophageal pH Monitoring 
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The acid exposure time (percentage time 
pH < 4) has been applied as the most appropriate 
character to distinguish physiologic from pathologic 
reflux [22]. 
Both catheter and wireless-based pH 
monitoring is performed based on the use of the high 
acid concentration for the diagnosis of oesophagal 
reflux. This can quantitatively examine the exposure 
of distal oesophagal and the relationship of symptoms 
with acid reflux episodes. The extensive and 
prolonged use of this technique has made it as the 
gold standard in the diagnosis of GERD [5]. It should 
be noted, that cutoff of 4.0 has been rejected by some 
experts, and they believe that a cutoff value of 5 can 
be more effective in distinguishing healthy individuals 
from patients with reflux. Moreover, some studies 
have stated that the range of PH between 3 and 6 is 
better than determining just one threshold for 
detection [23] [24]. 
The normal values of the acid exposure time 
in different centres have been widely computed from 
3.2 to 7.2 per cent. Additionally, the normative values 
of the acid exposure time have been reported in more 
than 30% of patients with reflux esophagitis [2] [22]. 
Accordingly, the acid exposure time is associated with 
limitation, therefore symptom–reflux correlation 
indexes have been provided to determine the 
association of reflux episodes with symptoms. Two 
important tools are available about this issue including 
symptom index (SI), symptom sensitivity index (SSI) 
and symptom association probability (SAP). The SI is 
described as the percentage of reflux associated 
symptom episodes which considered as positive when 
> 50%, representing at least half of the symptoms 
caused by GERD [5]. The SI is calculated by the 
following formula: 
× 100 
This index is not able to assess the total 
number of cases of reflux in its calculation. (Hog et al., 
2009). Moreover, there is a potential probability for 
false positive correlation results with an increase in 
the number of refluxes and a reduction in the number 
of symptoms. The symptom sensitivity index (SSI) has 
been developed as the percentage of symptom linked 
reflux episode based upon use of following formula 
[25] [26]. 
× 100 
SSI has increased by more than 10% the 
association of symptoms with reflux. The SSI and SI 
differ in their arbitrary cut off points and are based on 
the simultaneous frequency of reflux and symptoms, 
whereas the frequency of non-related reflux and 
episodes of symptoms are ignored in them [25] [27]. 
To eliminate these shortcomings, SAP can assess 
whether there are changes in the distribution of reflux 
episodes and symptoms during the monitoring by 
using statistical analysis, suggesting the meaningful 
probability of symptom–reflux correlation.  
A SAP > 95 can be determined as positive 
(Figure 2), [5] [28] [29]. Studies have revealed that the 
evaluation of SAP and SI for non-acid reflux could 
provide a diagnostic value of between 16% and 33% 
in patients evaluated in the treatment of PPI [2] [30] 
[31]. Furthermore, off-PPI SAP positivity for non-acidic 
reflux events is only 10 to 12% of significant 
diagnostic value [2] [11] [32]. 
 
Figure 2: The analysis of contingency diagram of four possible 
combinations of reflux and symptoms for each segment (SAP) 
 
The SI index is not able to assess the total 
number of cases of reflux in its calculation. A high 
amount of SI may be related to many parts of the 
patient's reflux episodes, and in this case, there is a 
great deal of chance. The superiority of the SAP is 
linked to its suitable statistical analysis [33]. 
The severity and clinical effect of the 
symptoms are not measured by SAP and SI, so 
nocturnal heartburn with unpleasant symptoms may 
be negative by using SAP and SI due to the 
calculation of these indicators based on the total 24-
hour monitoring period. 
Also, in low-reflux rate, the positive clinical 
value of SAP and SI is doubtful because the positive 
results in this case (low levels of reflux) are 
completely related to chance [2]. A study has 
suggested that SI and SAP are likely to be relevant in 
a patient with moderate to severe reflux. However, in 
patients with mild reflux, SI or SAP is not 
recommended for clinical decision making, such as 
whether the surgery should be performed [33] (Figure 
2). 
Despite the remarkable progress in the 
methods above, the lack of factual and reliable gold 
standard tests remains a problem, to which mentioned 
indicators are comparable [25] [34]. 
Two types of multichannel intraluminal 
 Foroutan et al. Advances in the Diagnosis of GERD Using the Esophageal Ph Monitoring 
_______________________________________________________________________________________________________________________________ 
_______________________________________________________________________________________________________________________________ 
Open Access Maced J Med Sci. 2018 Oct 25; 6(10):1934-1940.                                                                                                                                                 1937 
 
impedance (MII) are recommended for clinical 
evaluation that is a combination of MII with pH 
monitoring (MII-pH) and another MII conjugated with 
oesophagal manometry. MII has been initially 
provided to assess the movement of liquid, solid, and 
gas in the oesophagus without pH measurements 
[35]. 
MII-pH is another tool, which is developed 
with a combination of pH with impedance monitoring. 
This method is capable of distinguishing more reflux 
episodes based upon use of physical and chemical 
parameters of the refluxate, in which higher sensitivity 
and specificity for the diagnosis of GERD when 
comparing with other methods such as endoscopy or 
PH Monitoring. This method can be effective in 
determining acid reflux from non-acid reflux. 
Therefore, MII-pH indicates a situation that could 
rarely be affected by PPI treatment [36]. The 
advantages and disadvantages of MII-pH monitoring 
are summarised in Figure 3 [5] [37] [38]. As shown in 
the figure, this technique can analyse the symptoms 
associated with reflux in the event of acid 
suppression. As a result, negative results from MII-pH 
monitoring are very important for eliminating reflux 
compared to pH monitoring method [38] [39]. 
 
Figure 3: Advantages of multichannel intraluminal impedance (MII) 
 
Impedance-PH Monitoring increases the 
diagnostic value of the GERD by 15–20% [40] [41]. 
Compared to a pH monitoring test, the most important 
feature of this test is the ability to evaluate patients 
with persistent symptoms, despite the use of PPIs, 
Impedance-PH Monitoring can also be effectively 
applied to the clinical evaluation of patients suffering 
from NERD and extra-oesophageal reflux symptoms 
(Figure 3) [41] [42] [42] [44]. 
To help grasp the gastroesophageal reflux 
disease, MII-pH may be a very suitable technique for 
diagnosis of non-acid reflux. However, the clinical 
practice of this method has some limitations that have 
been previously explained by different studies 
controversial results can be found in the clinical study:  
1) Diagnosis of reflux episodes may be 
interrupted by lowering the impedance of MII-pH [45]. 
2) A catheter-based MII-pH monitoring will 
cause the patient's poor tolerance for monitoring pH-
impedance [45]. 
3) Dietary changes during the MI-pH 
evaluation may lead to a poor predictor of 
gastroesophageal reflux [45]. 
4) Studies have reported a different 
prevalence of week- acid reflux. In the terms of PH 
impedance analysis, studies have shown that 
moderate and severe esophagitis exhibit similar or 
slightly higher levels of weakly acidic reflux than 
healthy subjects [46] [47]. On the other hand, very 
similar finding has been achieved in terms of distal 
esophageal exposure to weakly acidic reflux ate in 
patients with a non-erosive reflux disease (NERD) and 
esophagitis [48]. Regarding the available residence, 
the division of patients with weak acid reflux and 
physiological acid reflux as reflex, can raise one 
question, which Alkaline reflux is rarely seen [46] [49]. 
5) In context of esophageal bolus transit, 
measurement of bolus clearance with internal 
impedance does not determine the abnormal 
functioning of the esophagus, especially in terms of 
minor malformations [45]. 
6) The existing tool does not determine the 
reliability between small and large volumetric storage 
by with failed bolus transit, where it limits the clinical 
interpretation and physiological diagnosis of 
pathologic fluid from pathologic fluid [45]. 
7) There are other limitations that make the 
diagnosis even more difficult such as pathologic 
changes in the esophageal mucosa (esophagitis), 
which may reduce the baseline impedance values, 
and consequently the diagnosis of bolus movement in 
the esophagus will be complicated [16] [50]. 
Moreover, mucosal changes in the esophagus may 
also contribute to the disruption of the esophagus and 
transition of esophagus material, where eventually 
lead to the maintenance of liquids in the esophagus 
[50]. 
8) In patients with impotence syndrome, it is 
possible that the level of esophageal acid exposure 
time and reflux be increased using MII-pH, which may 
lead to problems with the diagnosis of GERD. The 
flow of gas or air in the MII-pH monitoring method can 
be performed manually due to the lack of automatic 
tools. Applying a meal to manometry has been 
revealed to be time consuming for diagnosis and 
treatment strategies in terms of rumination, where 
lead to dissatisfaction with the patient's intubation [45] 
[51] [52]. 
9) MII-pH is not appropriate to predict 
response to treatment. Based on available studies, 
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MII parameters for non-acid reflux are not predictive of 
patients with GER in response to PPIs [8] [53] [54]. 
However, the base impedance is mentioned that could 
be a good predictor for the response to treatment with 
PPI [45]. A stud indicated that showed that base 
impedance might have the necessary efficacy in 
predicting therapeutic outcomes in patients who suffer 
from sensitivity of the esophagus and functional 
heartburn [45] [55] [56]. 
10) MII-pH monitoring was not effective in the 
postoperative period of antireflux surgery, in addition, 
false-positive results of the MII-PH monitoring (50%) 
was reported that makes the test clinically 
meaningless in asymptomatic individuals with 
negative PH monitoring [46] [57] [58]. 
11) There are other limitations that make the 
diagnosis even more difficult such as pathologic 
changes in the esophageal mucosa (esophagitis), 
which may reduce the baseline impedance values, 
and consequently the diagnosis of bolus movement in 
the esophagus will be complicated [16]. Moreover, 
mucosal changes in the esophagus may also 
contribute to the disruption of the esophagus and 
transition of esophagus material, where eventually 
lead to the maintenance of liquids in the esophagus 
[50]. 
12) The base impedance on the MSI-pH has 
been clinically showed to have the utility of measuring 
at sleeping period when there is no swallow [45]. 
13) High cost than pH monitoring (about 4-
fold). 
14) Lack of normative data among children 
 
 
Conclusion 
 
A 24-h oesophagal pH Monitoring can be 
effectively used to assess the potential relationship 
between symptoms and refluxes. Both catheter and 
wireless-based pH monitoring have been associated 
with the high acid concentration for the diagnosis of 
oesophagal reflux. Leading quantitative examined the 
exposure of distal oesophagal and the association of 
symptoms with acid reflux episodes. 
The wireless oesophagal pH test is 
associated with the patient's comfort and mobility, 
where have a significant effect for measuring over 
long periods of time. 
MII-pH is capable of distinguishing more 
reflux episodes based upon use of physical and 
chemical parameters of the refluxate, leads to a 
diagnosis of normal acid reflux from abnormal 
nonacidic reflux. It can be used to confirm gastro-
oesophagal reflux episodes, where has a sensitivity 
and specificity for diagnosing GERD in comparison 
with endoscopy or pH-metry. Evidence suggests that 
bolus clearance does not have the ability to diagnose 
effectively symptomatic patients from asymptomatic 
patients using intraluminal impedance, and 
consequently may be relatively limited in patients with 
minor manometric abnormalities [45]. 
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